ABT - CIK 0000001800
ABBOTT LABORATORIES (ABT) reported net income of $6.52B for fiscal year 2025, down 51.3% from $13.40B in fiscal 2024. The figure comes from the company's audited annual report as filed with the SEC.
| Quarter | Period end | net income |
|---|---|---|
| Q1 | 2025-03-31 | $1.32B |
| Q2 | 2025-06-30 | $1.78B |
| Q3 | 2025-09-30 | $1.64B |
Calendar quarters as standardized by SEC XBRL frames; the company's fiscal calendar may offset from calendar quarters.
ABBOTT LABORATORIES (ABT) reported net income of $6.52B for fiscal year 2025, down 51.3% from $13.40B in fiscal 2024. The figure comes from the company's audited annual report as filed with the SEC.
See the full ABT net income history or the complete income statement.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.